GT Biopharma
GTBP
GTBP
32 hedge funds and large institutions have $850K invested in GT Biopharma in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Holders
32
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$48.2K | |
| 2 | +$27.5K | |
| 3 | +$7.46K | |
| 4 |
AWS
Atria Wealth Solutions
New York
|
+$4.82K |
| 5 |
MAWA
Moss Adams Wealth Advisors
Seattle,
Washington
|
+$2.42K |
Top Sellers
| 1 | -$35.4K | |
| 2 | -$6.4K | |
| 3 | -$6.12K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.49K |
| 5 |
MCG
McCollum Christoferson Group
Amherst,
New York
|
-$5.46K |